This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
AU:B3
R03AC19(WHO)
AU:S4(Prescription only)UK:POM(Prescription only)US:℞-onlyIn general: ℞ (Prescription only)
6-hydroxy-8-{(1R)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl}-4H-1,4-benzoxazin-3-one
868049-49-4
11504295
7543
DB09080
9679097
VD2YSN1AFD
D10145
CHEBI:82700Y
ChEMBL605846
DTXSID601024792
Interactive image
COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1
InChI=1S/C21H26N2O5/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26)/t18-/m0/s1Key:COUYJEVMBVSIHV-SFHVURJKSA-N
Olodaterol(trade nameStriverdi Respimat) is an ultra-long-acting β adrenoreceptor agonist(ultra-LABA) used as an inhalation for treating people withchronic obstructive pulmonary disease(COPD). It is manufactured byBoehringer Ingelheim.